Geron Is Shutting Down Its Stem Cell Clinical Trial - NYTimes.com: There were “no signs” that the treatment was helping the patients. But that was not expected in the initial trial, which was mainly looking at safety. And so far, he said, there had been no sign of safety problems.
No comments:
Post a Comment